How to best define target populations of medicines in view of their coverage by the national health insurance scheme?

@article{Hamers2010HowTB,
  title={How to best define target populations of medicines in view of their coverage by the national health insurance scheme?},
  author={Francoise F Hamers and Jacques Massol and Patricia Maill{\`e}re},
  journal={Therapie},
  year={2010},
  volume={65 4},
  pages={341-5, 335-9}
}
The target population of a medicine may include different populations that may partially overlap including the population that has been evaluated in the clinical trials, the population for which the medicine provides an actual benefit (SMR), that for which the drug provides an improvement of the actual benefit (ASMR), etc. The definition of the target… CONTINUE READING